Almitas Capital LLC bought a new stake in shares of BlackRock Capital Allocation Term Trust (NYSE:BCAT – Free Report) during the 2nd quarter, Holdings Channel reports. The firm bought 44,339 shares of the company’s stock, valued at approximately $728,000.
A number of other hedge funds and other institutional investors also recently modified their holdings of BCAT. Wells Fargo & Company MN raised its stake in shares of BlackRock Capital Allocation Term Trust by 0.9% in the 4th quarter. Wells Fargo & Company MN now owns 495,095 shares of the company’s stock worth $7,402,000 after buying an additional 4,437 shares in the last quarter. Stifel Financial Corp raised its stake in shares of BlackRock Capital Allocation Term Trust by 30.3% in the 4th quarter. Stifel Financial Corp now owns 488,792 shares of the company’s stock worth $7,307,000 after buying an additional 113,628 shares in the last quarter. Karpus Management Inc. raised its stake in shares of BlackRock Capital Allocation Term Trust by 19.6% in the 4th quarter. Karpus Management Inc. now owns 26,600 shares of the company’s stock worth $398,000 after buying an additional 4,350 shares in the last quarter. Virtu Financial LLC bought a new stake in shares of BlackRock Capital Allocation Term Trust in the 4th quarter worth $315,000. Finally, Eagle Rock Investment Company LLC bought a new stake in shares of BlackRock Capital Allocation Term Trust in the 1st quarter worth $298,000. Institutional investors own 36.12% of the company’s stock.
BlackRock Capital Allocation Term Trust Price Performance
BCAT opened at $16.38 on Friday. BlackRock Capital Allocation Term Trust has a one year low of $13.67 and a one year high of $17.18. The stock’s fifty day moving average is $16.29 and its 200-day moving average is $16.22.
BlackRock Capital Allocation Term Trust Increases Dividend
Insider Transactions at BlackRock Capital Allocation Term Trust
In related news, major shareholder Saba Capital Management, L.P. sold 33,209 shares of BlackRock Capital Allocation Term Trust stock in a transaction on Monday, September 23rd. The stock was sold at an average price of $16.44, for a total value of $545,955.96. Following the transaction, the insider now directly owns 16,185,465 shares in the company, valued at approximately $266,089,044.60. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In the last 90 days, insiders have sold 72,876 shares of company stock valued at $1,197,155.
About BlackRock Capital Allocation Term Trust
–
Recommended Stories
- Five stocks we like better than BlackRock Capital Allocation Term Trust
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- CarMax’s Impressive Rally: What Investors Should Watch Next
- How to Use the MarketBeat Excel Dividend Calculator
- MarketBeat Week in Review – 9/23 – 9/27
- Overbought Stocks Explained: Should You Trade Them?
- Wake Up to This Biotech Stock That Still Has Big Potential Upside
Want to see what other hedge funds are holding BCAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BlackRock Capital Allocation Term Trust (NYSE:BCAT – Free Report).
Receive News & Ratings for BlackRock Capital Allocation Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Capital Allocation Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.